Yaroslav Tolstyak

Dr. Yaroslav Tolstyak

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
YTYaroslav Tolstyak
Yaroslav Tolstyak
RZRostyslav Zhuk
Rostyslav Zhuk
IYIgor Yakovlev
Igor Yakovlev
Nataliya ShakhovskaNataliya Shakhovska
Nataliya Shakhovska
MGMichal Gregus
Michal Gregus
NMNataliia Melnykova
Nataliia Melnykova
Machine learning is used to develop predictive models to diagnose different diseases, particularly kidney transplant survival prediction. The paper used the collected dataset of patients’ individual parameters to predict the critical risk factors associated with early graft rejection. Our study shows the high pairwise correlation between a massive subset of the parameters listed in the dataset. Hence the proper feature selection is needed to increase the quality of a prediction model. Several methods are used for feature selection, and results are summarized using hard voting. Modeling the onset of critical events for the elements of a particular set is made based on the Kapplan-Meier method. Four novel ensembles of machine learning models are built on selected features for the classification task. Proposed stacking allows obtaining an accuracy, sensitivity, and specifity of more than 0.9. Further research will include the development of a two-stage predictor.


22 December 2023 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
NMNataliya Matolynets
Nataliya Matolynets
JRJacek Roliński
Jacek Roliński
KLKhrystyna Lishchuk-Yakymovych
Khrystyna Lishchuk-Yakymovych
YTYaroslav Tolstyak
Yaroslav Tolstyak
The review focused on managing sepsis and septic shock patients by administering intravenous immunoglobulins (IVIG). Treatment outcomes and survival prognosis of septic patients were discussed in view of different regimens and dosages of IVIG. The principles of determining the appropriate dosage of IVIG in different medical facilities were compared. Own clinical case of complex treatment of septic shock using IVIG was proposed. The patient experienced a septic shock after transurethral resection of the prostate to treat a prostate abscess. Additionally, the patient was diagnosed with acute cerebrovascular disorder and various cardiovascular ailments, including type 2 diabetes mellitus and stage 2 chronic kidney disease. This septic patient was diagnosed with immunodeficiency disorder with lymphopenia, hypoproteinemia, procalcitoninemia, and significant secondary autoimmune inflammatory disorders. Despite the expected unfavorable prognosis, after comprehensive treatment with early application of moderate doses of IVIG, the patient’s condition stabilized, and organ functions remained satisfactory. Therefore, early administration of intravenous immunoglobulin had a favorable clinical outcome in the treatment of septic shock, thereby indicating the need to utilize a multidisciplinary approach, including involving an immunologist, in managing septic conditions.

5 June 2026 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
YTYaroslav Tolstyak
Yaroslav Tolstyak
UKUliana Kurnat
Uliana Kurnat
Introduction: Acute rejection is one of the most serious complications following liver transplantation. At the same time, elevated liver enzymes raise suspicion of the onset of acute graft rejection. Immunological markers, such as donor-specific antibodies and a panel of reactive antibodies, are key immunological indicators contributing to antibody-mediated graft rejection. Objective: To evaluate clinical, biochemical, and immunological markers associated with acute liver transplant rejection using modern statistical methods of survival analysis. Materials and Methods: A retrospective cohort of 50 liver transplant recipients was analyzed. The primary endpoint of the study was clinically diagnosed acute liver transplant rejection during the perioperative period. Time-to-event was calculated in days. Kaplan-Meier survival analysis with the log-rank test was performed for individual markers. Due to the low number of events, multivariate analysis was performed using Cox penalized regression. Results: There were three cases of acute graft rejection (6%). In exploratory analysis, differences in rejection-free survival were observed for Donor Specific Antibody and Panel Reactivity Antibody positivity (log-rank p ≈ 9.6 × 10⁻⁷), although positive groups were small (n = 2). A higher MELD (Model for End-Stage Liver Disease) score (>22) was associated with an increased risk of failure (log-rank p ≈ 0.035). Cox penalized regression identified MELD, Alkaline Phosphatase, and immunological markers, donor-specific antibody and panel reactive antibody, as exploratory predictors of graft rejection. Conclusions: Immunological sensitization and initial disease severity may contribute to acute liver transplant rejection. Generally, Cox regression models for survival analysis are useful for small cohorts with rare events.

Verified
Journal Article
Open access
PDF file
Vladyslav BardashVladyslav Bardash
Vladyslav Bardash
OSOleh Samchuk
Oleh Samchuk
YTYaroslav Tolstyak
Yaroslav Tolstyak
HDHanna Demydenko
Hanna Demydenko
ESEugen Sklyarov
Eugen Sklyarov
Conventional linear eplet-matching algorithms (HLAMatchmaker, HLAMM) evaluate primary sequence polymorphisms across human leukocyte antigen (HLA) loci without integrating three-dimensional (3D) steric accessibility and local physicochemical constraints. Here, we developed an exploratory computational antigenicity pipeline using AlphaFold 3 to evaluate 10,000 simulated European donor–recipient pairs across pre-computed, full-length HLA class I (HLA-A, -B, -C) and heterodimeric class II (HLA-DR, -DQ, -DP) complexes modeled in a standardized peptide-free conformation. Candidate eplets were sequentially screened using a spatial solvent-accessible surface area threshold (SASA ≥ 10.0 Å2) and an empirical biophysical exclusion gate (5th percentile of absolute net charge |Qnet| ≥ 0.3326 e and hydropathy Htotal ≥ −7.265, calibrated on N = 170 antibody-verified eplets). Across the simulated cohort (n = 10,000), filtration reduced median [Q1; Q3] eplet counts from 19 [12; 26] to 17 [10; 23] for HLA-A, 22 [15; 29] to 18 [12; 24] for HLA-B, 12 [7; 17] to 10 [7; 15] for HLA-C, 15 [10; 19] to 11 [7; 14] for HLA-DR, 12 [6; 17] to 9 [4; 14] for HLA-DQ, and 7 [3; 12] to 6 [2; 9] for HLA-DP. Component ablation demonstrated that 3D steric accessibility (SASA ≥ 10.0 Å2) accounted for the vast majority of eplet exclusions—87.8% in HLA-DR and HLA-DP and 58.2% to 69.1% across HLA-DQ and class I loci—whereas the registry-calibrated biophysical gate acted as a secondary refinement. Within the subset of simulated pairs initially exceeding the arbitrary ≥10-eplet linear cutoff, the proportion dropping below 10 eplets after filtering was low for class I (HLA-A: 4.4%, HLA-B: 8.0%, HLA-C: 13.2%) but substantially higher for class II high-load subsets: HLA-DQ (21.8%), HLA-DR (26.0%), and HLA-DP (33.7% of 3693 baseline high-load pairs). Furthermore, class II loci, particularly HLA-DP, exhibited weakened covariance between heuristic charge and hydropathy indices that persisted after 1:1 count-matched subsampling (ρmatched = −0.268) and partial correlation adjustment (ρpartial = −0.385). This dual-filter pipeline defines a restricted mathematical subset of spatially accessible and biophysically suprathreshold candidate eplets. Because this is a hypothesis-generating in silico framework, multicenter retrospective registry analyses and prospective clinical trials evaluating de novo donor-specific antibody formation, biopsy-proven rejection, and allograft survival are strictly required before clinical translation.

17 August 2022 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
IKIryna Kril
Iryna Kril
YTYaroslav Tolstyak
Yaroslav Tolstyak
HAHavrylyuk Anna
Havrylyuk Anna
HPHalina Potomkina
Halina Potomkina
VCValentina Chopyak
Valentina Chopyak
The presence of several different autoantibodies (auto-AT) at the same time is a specific peculiarity of the “autoantibody profile” of SLE (systemic lupus erythematosus). It is known that the induction of auto-AT formation involves both nonspecific and antigen-specific immunoregulatory disorders. In apoptosis, the primary changes in the cell membrane composition or/and the excretion of intracellular compounds into the intercellular milieu lead to an inflammatory reaction. The purpose of the study was to highlight the connection between apoptosis and secondary necrosis of granulocytes and mononuclear (lymphocytes and monocytes) with inflammation activity in patients with SLE to improve diagnosis and basic therapy efficacy. In patients with SLE, secondary necrosis of granulocytes was 3.4 times higher compared to healthy control. Moreover, the level of apoptotic monocytes was 1.87 times higher, and secondary necrosis of monocytes was 5.58 times higher than healthy control. The secondary necrosis of lymphocytes was higher 9.0 times than in the case of healthy control. The usage of Apolect technology in patients with SLE allows differentiating various cell types of immunological inflammation with the analysis of the degree of apoptosis and secondary necrosis of immunocompetent cells (granulocytes, monocytes, lymphocytes) to determine the aggressiveness of cytostatic therapy and predict the development of complications of this disease. Одночасна наявність декількох різних типів аутоантитіл (ауто-АТ) є специфічною ознакою «профілю аутоантитіл» СЧВ (системного червоного вовчака). Відомо, що в індукції утворення аутоАТ беруть участь як неспецифічні, так і антигенспецифічні порушення імунорегуляції. При апоптозі спостерігаються первинні зміни складу клітинної мембрани та/або викид внутрішньоклітинного вмісту у міжклітинне середовище, що призводить до розвитку запальної реакції. Мета дослідження — оцінка зв’язку апоптозу та вторинного некрозу гранулоцитів і мононуклеарів (лімфоцитів і моноцитів) із активністю запалення у хворих на СЧВ для покращення діагностики та ефективності базисної терапії. У хворих на СЧВ вторинний некроз гранулоцитів був у 3,4 рази вищий порівняно зі здоровим контролем. Крім того, рівень апоптичних моноцитів був вищим у 1,87 рази, а вторинний некроз моноцитів – у 5,58 разів порівняно зі здоровим контролем. Вторинний некроз лімфоцитів був вищим у 9,0 разів, ніж у здорового контролю. Застосування технології Apolect у хворих на СЧВ дозволяє диференціювати різні типи клітин та імунологічне запалення з ступенем апоптозу та вторинного некрозу імунокомпетентних клітин (гранулоцитів, моноцитів, лімфоцитів) для визначення агресивності цитостатичної терапії та прогнозування розвитку ускладнення цього захворювання